Page 83 - Read Online

Author Instructions

and they should only be used to improve the readability and language of manuscripts.
AI and AI-assisted technologies should be used under human control and supervision as they may generate incorrect or
prejudiced output, and they should not be listed as an author or co-author, nor cited as an author.
The use of AI and AI-assisted technologies should be disclosed by authors in their manuscripts, and a statement will be
required in the final publication.
OAE will keep monitoring the development and adjust the policy when necessary.

8. Conflict of Interests
OAE journals require authors to declare any possible financial and/or non-financial conflicts of interest at the end of their
manuscript and in the cover letter, as well as confirm this point when submitting their manuscript in the submission system.
If no conflicts of interest exist, authors need to state “The authors declare no conflicts of interest”. We also recognize that
some authors may be bound by confidentiality agreements, in which cases authors need to sate “The authors declare that
they are bound by confidentiality agreements that prevent them from disclosing their competing interests in this work”.

9. Editorial Process
9.1 Initial check
9.1.1 Initial manuscript check
New submissions are initially checked by the Managing Editor from the perspectives of originality, suitability, structure
and formatting, conflicts of interest, background of authors, etc. Poorly-prepared manuscripts may be rejected at this stage.
If your manuscript does not meet one or more of these requirements, we will return it for further revisions.

9.1.2 Publishing ethics
All manuscripts submitted to Metabolism and Target Organ Damage are screened using iThenticate powered by CrossCheck
to identify any plagiarized content. Your study must also meet all ethical requirements as outlined in our Editorial Policies.
If the manuscript does not pass any of these checks, we may return it to you for further revisions or decline to consider your
study for publication.
9.2 Editorial assessment
Once your manuscript has passed the initial check, it will be assigned to the Editor-in-Chief or Associate Editor who has
no conflict of interest on this manuscript to review. Regarding the Special Issue paper, after passing the initial check, the
manuscript will be successively assigned to an Assistant Editor, Guest Editor, and then to the Editor-in-Chief or Associate
Editor in the case of conflict of interest for the Guest Editor to review. The Editors from Editorial Board may reject
manuscripts that they deem highly unlikely to pass peer review without further consultation. Once your manuscript has
passed the editorial assessment, the Assistant Editor will start to organize peer-review.
9.3 Process
Metabolism and Target Organ Damage operates a single-blind review process. The technical quality of the research described
in the manuscript is assessed by a minimum of two independent expert reviewers. The Editors from Editorial Board are
responsible for the final decision regarding acceptance or rejection of the manuscript. For controversial manuscripts, the
Editor-in-Chief is responsible for making the final decision.

9.4 Decisions
Your research will be judged on technical soundness only, not on its perceived impact as judged by Editors or referees.
There are three possible decisions: Accept (your study satisfies all publication criteria), Invitation to Revise (more work is
required to satisfy all criteria), and Reject (your study fails to satisfy key criteria and it is highly unlikely that further work
can address its shortcomings).

10. Contact Us
Managing Editor
Doreen Deng
Email: editorialoffice@mtodjournal.net
Locations
Los Angeles Office
245 E Main Street, ste107, Alabama, CA 91801, USA
Tel: +1 323 9987086
Xi’an Office
Suite 1504, Plaza A, Xi’an National Digital Publishing Base, No. 996 Tiangu 7th Road, Gaoxin District, Xi’an 710077,
Shaanxi, China
Tel: +86 (0)29 8954 0089

XIII Metabolism and Target Organ Damage